Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afatinib in skull base chordoma
NCT05519917Phase 2Not yet recruiting
- Sponsor
- Huashan Hospital
- Start
- Oct 2022
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of afatinib in chordoma, sponsored by Huashan Hospital. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
afatinib
03
Conditions
chordoma
Beyond the preview
Go deeper on NCT05519917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05519917.